# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The New Term Loan maturity extends up to five years, through August 2029. Excess proceeds from the refinancing will result in a...
The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the preventi...
Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics Licens...
- Reuters